Allie Strickler

A recent study suggested that intentional weight loss could decrease the risk of endometrial cancer.

For patients with recurrent prostate cancer, adding hormonal therapy to post-surgical radiation treatment significantly improves survival, according to a recent study.

Gynecologic oncology and reproductive medicine expert discusses the new HPV vaccine recommendations and the importance of awareness for all HPV-caused cancers.

For patients with rectal cancer, the "watch-and-wait" approach of avoiding surgery after induction therapy is emerging as a treatment option.

For patients with HPV-related oropharyngeal squamous cell carcinoma, induction chemotherapy plus reduced-dose radiation and weekly cetuximab brought improvements for swallowing and nutritional status along with complete clinical responses.

A recent study shows that expedited surgery for patients with endometrial cancer is linked to an increased risk of mortality.

A recent study links NSAID use to an increased risk of endometrial carcinoma­–specific mortality.

Pembrolizumab linked to improved quality of life for patients with non-small cell lung cancer (NSCLC), according to data from KEYNOTE-024 trial.

Despite obesity as a risk factor for clear cell RCC, a high BMI is a prognostic factor for improved survival in patients with metastatic RCC.

While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and interval cytoreduction.